ADC Biotechnology

To cure together

ADC Biotechnology is creating innovative new technology, which aims to speed up, simplify and significantly lower the costs of the processes involved in the production of new antibody drug conjugates (ADCs). ADCs are antibodies that are attached to cancer-killing drugs using chemical ‘linkers’, allowing for targeted treatment of cancerous tissue.

Key facts

Sector - Healthcare

When Downing first invested - 2018

Website - http://adcbio.com